Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Treasury Shares: 2019-2025

Historic Treasury Shares for Keros Therapeutics (KROS) over the last 1 years, with Sep 2025 value amounting to $721,700.

  • Keros Therapeutics' Treasury Shares was N/A to $721,700 in Q3 2025 from the same period last year, while for Sep 2025 it was $721,700, marking a year-over-year change of. This contributed to the annual value of $34,557 for FY2019, which is N/A change from last year.
  • Per Keros Therapeutics' latest filing, its Treasury Shares stood at $721,700 for Q3 2025, which was down 16.83% from $867,775 recorded in Q2 2025.
  • Over the past 5 years, Keros Therapeutics' Treasury Shares peaked at $882,775 during Q1 2025, and registered a low of $721,700 during Q3 2025.
  • In the last 1 years, Keros Therapeutics' Treasury Shares had a median value of $867,775 in 2025 and averaged $824,083.